Back

Comparative effectiveness of sodium-glucose cotransporter-2 inhibitors across heart failure phenotypes

29 August 2026 (09:15 - 10:00)
Organised by: Logo
Congress Presentation Part of: Heart failure across the spectrum Epidemiology, Prognosis, Outcome ESC2026 Premium Access ESC Congress 2026 European Society of Cardiology

About the speaker

Photo
Doctor Licurgo Cruz

Metropolitan Hospital of Santiago, Santiago de los Caballeros (Dominican Republic)

5 More presentations in this session

Presentation thumbnail
Impact of selenium deficiency on clinical outcomes in elderly patients with acute heart failure: a prospective observational study
Doctor R. Ishida (Tokyo, JP)
Abstract Slides
Presentation thumbnail
Improving outcomes in HFpEF with advanced CKD: temporal trends from the SHEBAHEART Registry
Ms D. Sternik (IL)
Abstract Slides
Presentation thumbnail
Sex-specific differences in heart failure care in Germany: real-world evidence from claims data
Professor A. Baessler (Regensburg, DE)
Abstract Slides
Presentation thumbnail
Heart failure with preserved ejection fraction after surgical aortic valve replacement: prevalence, prognosis and predictors
Doctor B. Goessinger (Vienna, AT)
Abstract Slides
Presentation thumbnail
Clinical characteristics and in-hospital outcomes in octogenarians compared with younger patients with heart failure
Associate Professor A. Milovancev (Novi Sad, RS)
Abstract Slides

Access the full session

Session thumbnail
Heart failure across the spectrum

The Event

Event poster

ESC Congress 2026

29 August 2026 09:15 CET
You may be interested in
thumbnail
Congress Presentation
SGLT2 inhibitors in heart failure with preserved and reduced ejection fraction: a systematic review and meta-analysis
7 April 2022
thumbnail
Congress Presentation
SGLT2i effects depending on functional capacity in ATTR-CM
3 April 2025
thumbnail
Congress Presentation
Effect of SGLT2 inhibitors on diastolic function in patients with non-obstructive hypertrophic cardiomyopathy
29 June 2021
thumbnail
Congress Presentation
Prevention of new-onset heart failure and renoprotective effect with sodium-glucose cotransporter 2 inhibitors in patients with chronic kidney disease
29 August 2025

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources